Category: Psychedelics

Debra BorchardtMarch 7, 2024
ketamine.jpg

6min00
The JAMA (Journal of American Medical Association) Psychiatry published an article calling for more research and surveillance of ketamine treatments. Citing the rapidly shifting ketamine treatments, the three doctors Samuel T. Wilkinson, MD, Joseph J. Palamar, PhD, and Gerard Sanacora, MD, PhD noted that the fast spread of off-label uses is causing concern. Esketamine vs. ketamine The doctors […]

Debra BorchardtMarch 4, 2024
shutterstock_1563379993.jpg

3min00
Atai Life Sciences (NASDAQ: ATAI) announced that the first healthy participant has been dosed in its Phase 1b trial of VLS-01, an oral transmucosal film (OTF) formulation of N,N-dimethyltryptamine (DMT). It is a single-center, open-label study that is anticipated to enroll a total of 16 healthy participants. The participants will initially receive a single dose […]

Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.

 Sign up


About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


READ MORE



Recent Tweets

Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.